-
Product Insights
Corona Upstream Project , United Kingdom
Corona upstream project is located in North Sea, United Kingdom. The upstream project is owned by Apache Beryl I Limited. It will be operated by Apache Beryl I Limited. The project is currently in the announced stage and is expected to start operations in 2023. Corona Upstream profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and...
-
Product Insights
Italy Gov – Corona Prima Wind Park Expansion – Basilicate
Equip yourself with the essential tools needed to make informed and profitable decisions with our Italy Gov - Corona Prima Wind Park Expansion - Basilicate report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Sector Analysis
NewAzerbaijan Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Azerbaijan Beer and Cider Market Report Overview The Azerbaijan beer and cider market size was LCU807.9 million in 2022. The market is expected to grow at a CAGR of more than 8% during 2023-2028. Azerbaijan Beer and Cider Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the Azerbaijan Beer and Cider Market Forecast Download A Free Report Sample The Azerbaijan Beer and Cider market research report provides detailed data analysis of the beer and cider sector...
-
Sector Analysis
NewUAE Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
UAE Beer and Cider Market Report Overview The UAE beer and cider market size was LCU2.06 billion in 2022. The market is expected to grow at a CAGR of more than 5% during 2023-2028. UAE Beer and Cider Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the UAE Beer and Cider Market Forecast Download A Free Report Sample The UAE Beer and Cider market research report provides detailed data analysis of the beer and cider sector...
-
Sector Analysis
NewIsrael Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Israel Beer and Cider Market Report Overview The Israel beer and cider market size was LCU8.39 billion in 2022. The market is expected to grow at a CAGR of more than 3% during 2023-2028. Israel Beer and Cider Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the Israel Beer and Cider Market Forecast Download A Free Report Sample The Israel Beer and Cider market research report provides detailed data analysis of the beer and cider sector...
-
Sector Analysis
NewSingapore Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Singapore Beer and Cider Market Overview The Singapore beer and cider market size was LCU2.42 billion in 2022 and the market is expected to register a negative CAGR of less than 1% during 2023-2028. Singapore Beer and Cider Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the Singapore Beer and Cider Market Forecast Download A Free Report Sample The Singapore beer and cider market research report provides detailed data analysis of the beer and cider sector...
-
Sector Analysis
NewUruguay Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Uruguay Beer and Cider Market Overview The Uruguay beer and cider market size was LCU10.57 billion in 2022 and the market is expected to grow at a CAGR of more than 2% during 2023-2028. Uruguay Beer and Cider Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the Uruguay Beer and Cider Market Forecast Download A Free Report Sample The Uruguay Beer and Cider market research report provides detailed data analysis of the beer and cider sector...
-
Sector Analysis
NewParaguay Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Paraguay Beer and Cider Market Overview The Paraguay beer and cider market size was LCU6.52 trillion in 2022 and the market is expected to grow at a CAGR of more than 4% during 2023-2028. Paraguay Beer and Cider Market Outlook, 2022-2028 (LCU Trillion) Buy Full Report for More Insights into the Paraguay Beer and Cider Market Forecast Download A Free Report Sample The Paraguay Beer and Cider market research report provides detailed data analysis of the beer and cider sector...
-
Sector Analysis
NewCosta Rica Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Costa Rica Beer and Cider Market Overview The Costa Rica beer market size was LCU397.07 billion in 2022 and the market is expected to grow at a CAGR of more than 3% during 2023-2028. Costa Rica Beer Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the Costa Rica Beer and Cider Market Forecast Download A Free Report Sample The Costa Rica beer and cider market research report provides detailed data analysis of the beer and cider...
-
Sector Analysis
NewPhilippines Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Philippines Beer and Cider Market Report Overview The Philippines beer and cider market size was LCU358.89 million in 2022. The market is expected to grow at a CAGR of more than 15% during 2023-2028. Philippines Beer and Cider Market Outlook, 2022-2028 (LCU Million) Buy the Full Report for More Insights into the Philippines Beer and Cider Market Forecast Download A Free Report Sample The Philippines Beer and Cider market research report provides detailed data analysis of the beer and cider...
-
Sector Analysis
NewNew Zealand Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
New Zealand Beer and Cider Market Overview The New Zealand beer and cider market size was LCU4.85 billion in 2022 and the market is expected to grow at a CAGR of more than 4% during 2023-2028. New Zealand Beer and Cider Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the New Zealand Beer and Cider Market Forecast Download A Free Report Sample The New Zealand Beer and Cider market research report provides detailed data analysis of...
-
Company Profile
![]()
Constellation Brands Inc – Company Profile
Constellation Brands Inc (CBI) produces and markets alcoholic beverages. Its product portfolio includes wine, spirits, and beer. The company markets these products under Corona Extra, Corona Light, Corona Premier, Corona Familiar, Corona Refresca, Mount Veeder, My Favorite Neighbor, Casa Noble, Mi CAMPO, Kim Crawford, Robert Mondavi, High West, Cook's California Champagne, Ruffino, and SVEDKA, SIMI brand names. CBI distributes its products through retailers, wholesale distributors and through state alcohol beverage control agencies in states where the government acts as distributor....
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Burfiralimab in Hepatitis B
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Burfiralimab in Hepatitis BDrug Details:Burfiralimab (IMM-005) is under development for the treatment of chronic hepatitis B,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Burfiralimab in Pneumonia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Burfiralimab in PneumoniaDrug Details:Burfiralimab (IMM-005) is under development for the treatment of chronic hepatitis B, influenza-induced...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DAS-181 in Metapneumovirus Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.DAS-181 in Metapneumovirus InfectionsDrug Details: DAS-181 is under development for the treatment of influenza A virus,H1N1...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DAS-181 in Enterovirus Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DAS-181 in Enterovirus Infections Drug Details: DAS-181 is under development for the treatment of influenza A...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DAS-181 in Human Parainfluenza Virus 3 Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.DAS-181 in Human Parainfluenza Virus 3 InfectionsDrug Details: DAS-181 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ropeginterferon Alfa-2B La in Hepatitis C
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ropeginterferon Alfa-2B La in Hepatitis CDrug Details: Ropeginterferon alpha-2b (Besremi) is a long acting interferon. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ropeginterferon alfa-2b LA in Hepatitis D
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ropeginterferon Alfa-2B La in Hepatitis D Drug Details: Ropeginterferon alpha-2b (Besremi) is a long acting interferon....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ropeginterferon Alfa-2B La in Essential Thrombocythemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ropeginterferon Alfa-2B La in Essential ThrombocythemiaDrug Details: Ropeginterferon alpha-2b (Besremi) is a long acting interferon. It...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.